Posts Tagged NIMH

Meet 40 Experts and Innovators shaping Brain Health & Enhancement on December 5-7th, at the 2017 SharpBrains Virtual Summit

We are proud to announce these 40 confirmed Summit Speakers, Chairs and Judges at the 2017 SharpBrains Virtual Summit on December 5-7th. What an incredible brain trust shaping the future of brain health and enhancement!

Here are just a few:

Dr. Adam Gazzaley, Professor of Neurology and Founding Director of Neuroscape at UCSF

Dr. Gazzaley is a faculty member in the Neurology, Physiology and Psychiatry departments, and Director of a cognitive neuroscience laboratory conducting research on the neural mechanisms of attention and memory. Dr. Gazzaley is also co-founder and Chief Science Advisor of Akili Interactive Labs, a company developing therapeutic video games, and co-founder and Chief Scientist of JAZZ Venture Partners, a venture capital firm investing in experiential technology to improve human performance.

Dr. Adam Haim, Chief of the Clinical Trials Operations and
Biostatistics Branch at the NIMH

Dr. Haim oversees the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs at the National Institute of Mental Health (NIMH). Both programs help small businesses fund R&D with strong potential for technology commercialization, and a significant portion of their current grant portfolio is focused on the development and evaluation of mHealth interventions and digital health technology.

Alexandra Morehouse

Alexandra Morehouse, CMO of Banner Health

Alexandra M. Morehouse is Senior Vice President & Chief Marketing Officer for Banner Health, one of the nation’s largest nonprofit health systems. Prior to Banner Health, she was the Vice President of Brand Management at Kaiser Permanente, and CMO of AAA. She has served on the boards of the Harvard Business School Community Partners, SnapFish, Yerba Buena Center for the Arts, ODC Dance, and UC Davis.

Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization (NIO)

Dr. Fenney runs the Neurotechnology Industry Organization, a global trade association representing companies involved in neuroscience, brain research institutes and patient advocacy groups. Prior to NIO, Alison was Manager of Industry Relations at the Ontario Brain Institute (OBI) in Canada, and also worked in Equity Research at Bloom Burton & Co.

Álvaro Fernández, CEO and Editor-in-Chief of SharpBrains

Álvaro Fernández, a member of the World Economic Forum’s Council on the Future of Human Enhancement, runs SharpBrains, an independent market research firm tracking health and performance applications of brain science. Mr. Fernandez is the co-author of “The SharpBrains Guide to Brain Fitness: How to Optimize Brain Health and Performance at Any Age”, and the Editor-in-chief of SharpBrains’ market report on Pervasive Neurotechnology.

 

For more, here you can Meet 40 Experts and Innovators at the frontier of Brain Health & Enhancement.

 

Advertisements

Leave a Comment

May e-newsletter: MIT Solve launches Brain Health Challenge, asking “How can every person improve their brain health and mental resilience?”

New thinking

New research

New tools

 

 

Have a great month of June and, for those based in the US, a great Memorial Day weekend,

 

The SharpBrains Team

Leave a Comment

5 Facts You Need To Know To Understand, Navigate And Enjoy The Digital Brain Health Revolution

Hundreds of companies around the globe, now including Elon Musk’s Neuralink and even Facebook,  are researching and developing new ways to help brain owners be smarter, sharper, and healthier.

What explains this flurry of activity? Where may it be headed?

To help you understand what’s going on, let me highlight five key facts that emerged from the recent SharpBrains Virtual Summit, where 200+ participants in 16 countries shared and discussed the latest about neurotech­nolo­gy, brain health and digital health.

 

Fact 1. There are 7.5 billion human brains out there, and everyone needs help

Consider all unmet needs derived from the traditional pharma-exclusive approach to brain health.

Learning and cognitive disabilities in children are growing significantly, from ADHD and OCD, to autism. The related emotional and economic burden is substantial — yet, over 60-70% of those with treatment have poor outcomes, and many who need help don’t get any.
Read the rest of this entry »

Leave a Comment